Jackson Creek Investment Advisors LLC Trims Stake in DocuSign, Inc. (NASDAQ:DOCU)

Jackson Creek Investment Advisors LLC lessened its position in DocuSign, Inc. (NASDAQ:DOCU) by 17.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,520 shares of the company’s stock after selling 1,836 shares during the quarter. Jackson Creek Investment Advisors LLC’s holdings in DocuSign were worth $766,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Freestone Capital Holdings LLC boosted its position in shares of DocuSign by 38.0% during the fourth quarter. Freestone Capital Holdings LLC now owns 22,104 shares of the company’s stock valued at $1,988,000 after buying an additional 6,085 shares during the period. Raymond James Financial Inc. bought a new stake in shares of DocuSign during the 4th quarter worth approximately $38,449,000. Arizona State Retirement System grew its position in DocuSign by 0.5% in the 4th quarter. Arizona State Retirement System now owns 58,954 shares of the company’s stock valued at $5,302,000 after acquiring an additional 302 shares during the last quarter. Aigen Investment Management LP purchased a new stake in DocuSign in the fourth quarter worth $432,000. Finally, Proficio Capital Partners LLC bought a new stake in shares of DocuSign during the fourth quarter worth $4,724,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

DocuSign Stock Performance

Shares of DocuSign stock opened at $79.83 on Friday. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The company has a market capitalization of $16.13 billion, a PE ratio of 16.46, a P/E/G ratio of 6.94 and a beta of 1.02. The company has a 50-day simple moving average of $89.05 and a two-hundred day simple moving average of $78.45.

Insider Buying and Selling

In other DocuSign news, insider Robert Chatwani sold 14,800 shares of the firm’s stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $97.76, for a total value of $1,446,848.00. Following the completion of the sale, the insider now owns 73,414 shares of the company’s stock, valued at approximately $7,176,952.64. This trade represents a 16.78 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the completion of the transaction, the director now directly owns 906,430 shares of the company’s stock, valued at $87,959,967.20. The trade was a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 686,010 shares of company stock worth $66,102,694 in the last 90 days. 1.66% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. Jefferies Financial Group raised their price target on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Hsbc Global Res upgraded DocuSign to a “moderate sell” rating in a report on Friday, December 6th. UBS Group raised their price objective on DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. Finally, JPMorgan Chase & Co. increased their price target on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research report on Tuesday, December 3rd. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $92.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.